Recent decades have seen unimaginable scientific discoveries and innovations, let alone benefits were inefficient to patients. That is why we study methods to integrate technological and medical advancements to come up with the most efficient, low-cost and plentiful patient-centered care.

Thanks to many collaborations, we integrate and analyse complex data from genomics, exposome, (para)-clinical measurements, medications, and patient-reported outcomes to unveil (causal) factors associated with and predicting the clinical course and outcome of complex diseases of the digestive system, psychosis, cancer, and radiotherapy. We near crazy scientific innovations to the implementation of personalised management and disease prevention. We are going to embrace Personalised-Medicine!

Our Main filed of research concern public health topics with focus on elements of personalised medicine constituting of:

  • Genetic, clinical & epidemiological approaches to analyse life course real data,
  • Complex genetic, gene-exposome, pharmacogenetic & network analyses,
  • Integration of “multi-omics” approach and tele-medicinal monitoring practice,
  • Distinguish and prediction of disease courses & clinical outcomes,
  • Omic-based prediction of response to interventions,
  • Implementation of personalised medicine in health care,
  • Teaching and knowledge dissemination in genetic and epidemiological methodology.

A highly valued scientific relevance

We focus on understanding and implementation of personalised medicine as a method to bridge the gap between the molecular biology, clinic and society.

  • understanding of pathogenically relevant factors required to implement personalised medicine.
  • delivering and optimising the right treatment to the right target at the right moment.
  • bridging scientific advanced into clinical practice to form “multi-omics individual approach”.
  • eventually to the implementation of personalised medicine in practice.
  • Patients

    Personalised Medicine is a health care process that aims to replace less effective, costly and lengthy traditional disease management strategies with more effective and efficient ones, eventually reducing the burden on the health care system.

    Public health

    PM demands and will lead to changes in medical guidelines and health care processes. Implementation of PM extends from the monitoring and management of care in clinics to modifications of patients’ daily activities at home, at work and in the community.


Small profile photo of B.Z. Alizadeh
Behrooz Z. Alizadeh Genetic Epidemiologist, Precision Medicine

University Medical Center Groningen (UMCG)
Department of Epidemiology
PO Box 30.001
9700 RB Groningen
The Netherlands

Visiting Address
University Medical Center Groningen (UMCG)
Department of Epidemiology
Hanzeplein 1
9713 GZ Groningen

location: Zusterhuis B1 ING 27